Aytu reports Q1 fiscal 2027 results amid pending Rosemont acquisitionNov 16Quarterly updateAytu Biopharma, Incgepirone
Aytu reports first full launch quarter for EXXUA, fiscal 2026 resultsSep 22Quarterly updateAytu Biopharma, Incgepirone